Natural anti-inflammatory compounds for the management and adjuvant therapy of inflammatory bowel disease and its drug delivery system

被引:16
|
作者
Kim, Hyun-Jo [1 ]
Neophytou, Constantinos [2 ]
机构
[1] Jeil Pharmaceut Co Ltd, Yongin 449861, South Korea
[2] Yasoo Hlth Ltd, CY-1307 Nicosia, Cyprus
关键词
Mastic oil; Inflammatory Bowel Disease (IBD); Crohn Disease (CD); Drug Delivery System (DDS); Colon targeting; pH dependent polymer; LENTISCUS VAR. CHIA; PISTACIA-LENTISCUS; OIL; GUM;
D O I
10.1007/s12272-009-1704-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This project aims to investigate the anti-inflammatory properties of mastic [(Pistacia lentiscus var. Chia (Anacardiaceae)] extracted from the Chios mastic plant to help reduce intestinal inflammation in inflammatory bowel disease patients. Mastic and mastic resin were obtained from the Chios Mastiha Growers Association (www.mastihashop.com). The resin was ground into a fine powder using a pestle and mortar and formulated in factorial design manner. Evaluation of the efficacy of specific anti-inflammatory/antioxidant compounds in mitigating the clinical colitis parameters in a mouse model of colitis were performed with mastic itself and combination of tocopherol compounds. Colonic drug delivery system was developed consisting of two compartment model and its release profile was also investigated.
引用
收藏
页码:997 / 1004
页数:8
相关论文
共 50 条
  • [31] Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: Current perspectives
    Cipolla, G
    Crema, F
    Sacco, S
    Moro, E
    De Ponti, F
    Frigo, G
    PHARMACOLOGICAL RESEARCH, 2002, 46 (01) : 1 - 6
  • [32] Use of nonsteriodal anti-inflammatory drugs in outpatients with inflammatory bowel disease
    Bonner, GF
    Vennamaneni, S
    GASTROENTEROLOGY, 2001, 120 (05) : A269 - A269
  • [33] Anti-inflammatory therapy for cardiovascular disease
    Kosmas, Constantine E.
    Silverio, Delia
    Sourlas, Andreas
    Montan, Peter D.
    Guzman, Eliscer
    Garcia, Mario J.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (07)
  • [34] Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease
    Gironella, M
    Iovanna, JL
    Sans, M
    Gil, F
    Peñalva, M
    Closa, D
    Miquel, R
    Piqué, JM
    Panés, J
    GUT, 2005, 54 (09) : 1244 - 1253
  • [35] Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease
    Boaru, Diego Liviu
    Fraile-Martinez, Oscar
    De Leon-Oliva, Diego
    Garcia-Montero, Cielo
    De Castro-Martinez, Patricia
    Miranda-Gonzalez, Alejandro
    Saez, Miguel A.
    Munon-Zamarron, Leticia
    Castillo-Ruiz, Elisa
    Barrena-Blazquez, Silvestra
    Canonez-Zafra, Rafael
    Alvarez-Mon, Miguel Angel
    Toledo-Lobo, Maria, V
    Minaya-Bravo, Ana M.
    Lopez-Gonzalez, Laura
    Diaz-Pedrero, Raul
    Saz, Jose, V
    Albillos, Agustin
    Alvarez-Mon, Melchor
    Guijarro, Luis G.
    Ortega, Miguel A.
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (14): : 5608 - 5672
  • [36] Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker
    Danese, S.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S225 - S228
  • [37] Nutrition and inflammatory bowel disease: primary or adjuvant therapy
    Tighe, Mark P.
    Cummings, J. R. Fraser
    Afzal, Nadeem A.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2011, 14 (05): : 491 - 496
  • [38] Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease
    OBanion, MK
    Finch, CE
    NEUROBIOLOGY OF AGING, 1996, 17 (05) : 669 - 671
  • [39] Unveiling the anti-inflammatory potential of 11β,13-dihydrolactucin for application in inflammatory bowel disease management
    Matos, Melanie S.
    Avila-Galvez, Maria angeles
    Gonzalez-Sarrias, Antonio
    Silva, Nuno-Valerio
    Crespo, Carolina Lage
    Jacinto, Antonio
    Serra, Ana Teresa
    Matias, Ana A.
    Nunes dos Santos, Claudia
    FOOD & FUNCTION, 2024, 15 (18) : 9254 - 9271
  • [40] CARDIOVASCULAR BIOMARKERS, A USEFUL TOOL IN ANTI-INFLAMMATORY DRUG THERAPY SAFETY MONITORING AND DISEASE MANAGEMENT
    Pop, C.
    Mogosan, C.
    Farcas, A. M.
    Loghin, F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 67 - 67